Liposome-paclitaxel and carboplatin combination chemoradiotherapy for patients with locally advanced esophageal squamous cell carcinoma

CONCLUSIONS: Liposome-paclitaxel and carboplatin concurrent with radiotherapy is a safe and effective modality for locally advanced ESCC. Further clinical investigation are warranted to evaluate the efficacy of this regimen.PMID:33958272 | DOI:10.1016/j.canrad.2021.01.008

Source: Cancer Radiotherapie - May 7, 2021 Category: Cancer & Oncology Authors: J Zeng X Cui L Cheng Y Chen X Du L Sheng Source Type: research